Practical Considerations in Breast Cancer

EP. 1: Overview of HER2-Targeted Therapies in Breast Cancer

January 22nd 2014

EP. 2: Treating Low-Risk HER2-Positive Breast Cancer

January 22nd 2014

EP. 3: Frontline Pertuzumab for Metastatic Breast Cancer

January 22nd 2014

EP. 4: PIK3CA Mutations in HER2-Positive Breast Cancer

January 22nd 2014

EP. 5: T-DM1 in HER2-Positive Metastatic Breast Cancer

January 22nd 2014

EP. 6: Recommendations for Optimal HER2 Testing in Breast Cancer

January 22nd 2014

EP. 7: Role of Lapatinib in HER2-Positive Breast Cancer

January 22nd 2014

EP. 8: Novel Drug Development in Breast Cancer

January 22nd 2014

EP. 9: Phase III Clinical Trials in HER2-Positive Breast Cancer

January 22nd 2014

EP. 10: Case Study: HER2-Positive Oligometastatic Breast Cancer

January 22nd 2014

EP. 11: Upfront Treatment of HR-Positive MBC

January 22nd 2014

EP. 12: Next Steps for Everolimus in Metastatic Breast Cancer

January 22nd 2014

EP. 13: CDK4/6 Inhibitors in Metastatic Breast Cancer

January 22nd 2014

EP. 14: Chemotherapeutics in Metastatic Breast Cancer

January 22nd 2014

EP. 15: Preventing Skeletal-Related Events in Breast Cancer

January 22nd 2014

EP. 16: Conclusion: Future Direction of Breast Cancer Treatment

January 22nd 2014